Albeit preliminary, our own results support the interesting hypothesis that the HDAC6P856S protein variant may be acting synergistically with the GFAP-εR430H mutation, conditioning the development of the severe MND phenotype of Pt2. This evidence concerns the gene GFAP and mild neurocognitive disorder.